AI

AI

Ryght AI and Biorasi to partner on AI

AI

Novel gene therapy for ALS cleared for trials in US and China

AI

Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins

AI

KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations

AI

Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA

AI

Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance

AI

Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity

AI

I-Corps Hub West accelerates deeptech commercialisation in western US